Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin–Tazobactam in Obese Patients

BACKGROUND AND OBJECTIVE: Standard piperacillin–tazobactam (P-T) dosing may be suboptimal in obesity, but high-dose regimens have not been studied. We prospectively evaluated the pharmacokinetics and pharmacodynamics of standard- and high-dose P-T in obese adult inpatients. METHODS: Those receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Veillette, John J., Winans, S. Alexander, Maskiewicz, Victoria K., Truong, James, Jones, Ronald N., Forland, Steven C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093170/
https://www.ncbi.nlm.nih.gov/pubmed/33743171
http://dx.doi.org/10.1007/s13318-021-00677-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093170/
https://www.ncbi.nlm.nih.gov/pubmed/33743171
http://dx.doi.org/10.1007/s13318-021-00677-1

Ejemplares similares